Literature DB >> 31073823

Incidence and Consequence of Nontarget Embolization Following Bland Hepatic Arterial Embolization.

Brandon J Newgard1, George I Getrajdman2, Joseph P Erinjeri2, Anne M Covey2, Lynn A Brody2, Constantinos T Sofocleous2, Karen T Brown2.   

Abstract

PURPOSE: Estimate the incidence of nontarget embolization (NTE) as identified on immediate post-hepatic artery embolization CT.
MATERIALS AND METHODS: Two hundred hepatic embolizations performed with particles alone (bland embolization) in 147 patients between August 16, 2013 and August 26, 2014 with immediate post-procedure CT were retrospectively reviewed. Arterial anatomy, vessels treated, imaging findings of NTE, patient demographics, length of hospital stay following embolization, and procedure-related complications were recorded. The data were analyzed using two-sided t-tests and chi-squared tests.
RESULTS: Evidence of NTE was seen on post-procedure CT in 64 of 200 cases (64/200, 32%). Six organs were affected, with 69 discrete sites in 64 patients. The majority (49/69, 71.0%) involved the gallbladder. The mean length of hospital stay (LOS) for patients with and without NTE was 2.9 ± 1.5 nights (range 1-7) and 2.9 ± 2.3 nights (range 0-21), respectively (P = 0.81). NTE was more common following embolization of replaced or accessory hepatic vessels. There were three complications in the NTE group (3/64, 4.7%) following the embolization procedure, one of which was cholecystitis directly related to NTE. The other two were one incidence each of contrast-induced nephropathy and pneumonia. In the group without NTE, seven complications occurred (7/136, 5.1%, P = 0.889), including one death resulting from hepatic failure, two gastrointestinal bleeds, two hepatic abscesses, flash pulmonary edema, and pancreatitis.
CONCLUSION: Unanticipated NTE is not uncommon after bland hepatic artery embolization, particularly after treating accessory or replaced vessels, but does not increase complications or LOS. LEVEL OF EVIDENCE: Level 2b, Retrospective Cohort.

Entities:  

Keywords:  Complication; Embolization; Hepatic malignancy

Mesh:

Year:  2019        PMID: 31073823     DOI: 10.1007/s00270-019-02229-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.797


  1 in total

1.  To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.

Authors:  Xiao Yang; Tingting Lan; Hui Zhong; Zujian Zhang; Hui Xie; Youwei Li; Wen Huang
Journal:  J Healthc Eng       Date:  2022-03-21       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.